L

Lite Strategy

LITS

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Market Performance

Tokenized Assets

TickerExchangePrice24HSpreadLiquidity ±2%24H VolumeOIFundingMax LeverageFees

Fundraising

RoundAmountValuationDateSource
Investor
Post-IPO$ 100M--
Jul 22, 2025
--

Follow Updates

Follow Lists

People